| $337M | ||
| $259M | ||
| $100M | ||
| $79M | ||
| $60M | ||
| $58M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.
Over the last 12 months, insiders at Turnstone Biologics Corp. have bought $0 and sold $0 worth of Turnstone Biologics Corp. stock.
On average, over the past 5 years, insiders at Turnstone Biologics Corp. have bought $7.7M and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 225,000 shares for transaction amount of $2.7M was made by Versant Ventures V, LLC (10 percent owner) on 2023‑07‑25.
| 2023-07-25 | Versant Ventures V, LLC | 10 percent owner | 225,000 22.5018% | $12.00 | $2.7M | -75.44% | ||
| 2023-07-20 | ORBIMED ADVISORS LLC | 416,666 41.6699% | $12.00 | $5M | -74.45% |
| ORBIMED ADVISORS LLC | 3099265 13.3933% | $1.12M | 1 | 0 | <0.0001% | |
| Versant Ventures V, LLC | 10 percent owner | 2726322 11.7817% | $983,929.61 | 1 | 0 | <0.0001% |
$8,253,997 | 122 | -53.40% | $10.19M | |
$63,749,694 | 24 | -12.24% | $7.91M | |
$1,616,354 | 20 | -12.22% | $8.86M | |
$29,469,413 | 18 | 30.40% | $9.4M | |
$613,181 | 18 | -20.90% | $5.61M | |
$1,556,551 | 15 | -25.43% | $5.82M | |
$105,917 | 11 | -28.06% | $10.14M | |
$232,642 | 8 | -8.03% | $9.02M | |
$603,773 | 6 | -56.12% | $8.7M | |
$40,324 | 6 | 31.82% | $7.69M | |
$73,934 | 5 | -39.52% | $9.38M | |
$1,028,395 | 4 | -11.91% | $7.65M | |
$126,379 | 4 | -23.04% | $9.04M | |
$76,299 | 4 | 11.60% | $6.74M | |
$149,778 | 4 | -45.16% | $7.2M | |
$726,438 | 4 | -72.85% | $5.22M | |
Turnstone Biologics Corp. (TSBX) | $7,699,992 | 2 | -74.95% | $8.35M |
$44,529 | 2 | -30.33% | $8.57M | |
$4,423 | 2 | 3.27% | $6.83M |
| Increased Positions | 6 | +13.64% | 1M | +11.52% |
| Decreased Positions | 19 | -43.18% | 2M | -18.48% |
| New Positions | 3 | New | 1M | New |
| Sold Out Positions | 9 | Sold Out | 2M | Sold Out |
| Total Postitions | 31 | -29.55% | 9M | -6.97% |
| Orbimed Advisors Llc | $1,085.00 | 13.48% | 3.1M | 0 | 0% | 2024-12-31 |
| Fmr Llc | $414.00 | 5.15% | 1.18M | +11,056 | +0.94% | 2024-12-31 |
| Point72 Asset Management, L.P. | $327.00 | 4.06% | 934,364 | +2,138 | +0.23% | 2024-12-31 |
| Pfm Health Sciences, Lp | $326.00 | 4.05% | 932,348 | 0 | 0% | 2024-12-31 |
| Bank Of America Corp /De/ | $312.00 | 3.88% | 891,526 | -20,215 | -2.22% | 2024-12-31 |
| Citadel Advisors Llc | $241.00 | 3% | 689,213 | 0 | 0% | 2024-12-31 |
| Vanguard Group Inc | $203.00 | 2.52% | 578,995 | 0 | 0% | 2024-12-31 |
| 72 Investment Holdings, Llc | $192.00 | 2.39% | 549,980 | 0 | 0% | 2024-12-31 |
| Sectoral Asset Management Inc | $181.00 | 2.25% | 517,648 | 0 | 0% | 2024-12-31 |
| Fil Ltd | $67.00 | 0.84% | 192,657 | 0 | 0% | 2024-12-31 |